UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Growth signals, inflammation, and vascular perturbations: mechanistic links between obesity, metabolic syndrome, and cancer

Arteriosclerosis, thrombosis, and vascular biology, 2012-08, Vol.32 (8), p.1766-1770

2012

Volltextzugriff (PDF)

Platelet Factor 4/Heparin Antibodies in Blood Bank Donors

American journal of clinical pathology, 2010-11, Vol.134 (5), p.774-780

2010

Volltextzugriff (PDF)

Argatroban Therapy in Heparin-Induced Thrombocytopenia With Hepatic Dysfunction

Chest, 2006-05, Vol.129 (5), p.1167-1175

2006

Volltextzugriff (PDF)

Effects of Argatroban Therapy, Demographic Variables, and Platelet Count on Thrombotic Risks in Heparin-Induced Thrombocytopenia

Chest, 2006-06, Vol.129 (6), p.1407-1416

2006

Volltextzugriff (PDF)

When heparins promote thrombosis : Review of heparin-induced thrombocytopenia

Circulation (New York, N.Y.), 2005-05, Vol.111 (20), p.2671-2683

2005

Volltextzugriff (PDF)

How Frequently Is Venous Thromboembolism in Heparin-Treated Patients Associated With Heparin-Induced Thrombocytopenia?

Chest, 2006-09, Vol.130 (3), p.681-687

2006

Volltextzugriff (PDF)

Platelet factor 4/heparin antibody (IgG/M/A) in healthy subjects: a literature analysis of commercial immunoassay results

Journal of thrombosis and thrombolysis, 2008-08, Vol.26 (1), p.55-61

2008

Volltextzugriff (PDF)

Heparin-induced Thrombocytopenia, a Prothrombotic Disease

Hematology/oncology clinics of North America, 2007-02, Vol.21 (1), p.65-88

2007

Volltextzugriff (PDF)

Argatroban Anticoagulation in Renal Dysfunction: A Literature Analysis

Nephron. Clinical practice, 2008-01, Vol.109 (2), p.c80-c94

2008

Volltextzugriff (PDF)

Calorie restriction and cancer prevention: a mechanistic perspective

Cancer & metabolism, 2013-03, Vol.1 (1), p.10-10, Article 10

2013

Volltextzugriff (PDF)

The Pharmacokinetics and Pharmacodynamics of Argatroban: Effects of Age, Gender, and Hepatic or Renal Dysfunction

Pharmacotherapy, 2000-03, Vol.20 (3), p.318-329

2000

Volltextzugriff (PDF)

A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease

Kidney international, 2004-12, Vol.66 (6), p.2446-2453

2004

Volltextzugriff (PDF)

Argatroban for Suspected Heparin-Induced Thrombocytopenia: Contemporary Experience at a Large Teaching Hospital

Journal of intensive care medicine, 2006-03, Vol.21 (2), p.86-92

2006

Volltextzugriff (PDF)

Reducing thrombotic complications in the perioperative setting : An update on heparin-induced thrombocytopenia

Anesthesia and analgesia, 2007-09, Vol.105 (3), p.570-582

2007

Volltextzugriff (PDF)

Heparin-induced thrombocytopenia in the emergency department

Annals of emergency medicine, 2004-11, Vol.44 (5), p.511-515

2004

Volltextzugriff (PDF)

Reducing Harm Associated with Anticoagulation: Practical Considerations of Argatroban Therapy in Heparin-Induced Thrombocytopenia

Drug safety, 2009-01, Vol.32 (3), p.203-218

2009

Volltextzugriff (PDF)

Compatibility of argatroban with abciximab, eptifibatide, or tirofiban during simulated Y-site administration

American journal of health-system pharmacy, 2005-07, Vol.62 (13), p.1381-1384

2005

Volltextzugriff (PDF)

Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia

Catheterization and cardiovascular interventions, 2002-10, Vol.57 (2), p.177-184

2002

Volltextzugriff (PDF)

Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS-1): A randomized, placebo-controlled safety study

Stroke (1970), 2004-07, Vol.35 (7), p.1677-1682

2004

Volltextzugriff (PDF)

Risk Factors for Major Bleeding in Patients With Heparin-induced Thrombocytopenia Treated With Argatroban: A Retrospective Study

Journal of cardiovascular pharmacology, 2008-12, Vol.52 (6), p.561-566

2008

Volltextzugriff (PDF)

Etiology and Assessment of Hypercoagulability with Lessons from Heparin-Induced Thrombocytopenia

Anesthesia and analgesia, 2011, Vol.112 (1), p.46-58

2011

Volltextzugriff (PDF)

Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy

Critical care medicine, 2004-04, Vol.32 (4), p.976-980

2004

Volltextzugriff (PDF)

Reduced argatroban doses after coronary artery bypass graft surgery

The Annals of pharmacotherapy, 2008-03, Vol.42 (3), p.309-316

2008

Volltextzugriff (PDF)

Argatroban Anticoagulation in Obese Versus Nonobese Patients: Implications for Treating Heparin-induced Thrombocytopenia

Journal of clinical pharmacology, 2007-08, Vol.47 (8), p.1028-1034

2007

Volltextzugriff (PDF)

Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy

The Annals of pharmacotherapy, 2005-10, Vol.39 (10), p.1601-1605

2005

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(79)
Berichte
(1)

Sprache

Englisch
(80)

Erscheinungsjahr

n.n

Thema

Humans
(61)
Life Sciences & Biomedicine
(60)
Science & Technology
(60)
Heparin - Adverse Effects
(38)
Male
(38)
Biological And Medical Sciences
(36)
Thrombocytopenia - Chemically Induced
(36)
Argatroban
(35)
Medical Sciences
(35)
Female
(34)
Middle Aged
(33)
Heparin-Induced Thrombocytopenia
(30)
Aged
(27)
Thrombocytopenia - Drug Therapy
(27)
Anticoagulants - Adverse Effects
(25)
Pipecolic Acids - Therapeutic Use
(22)
Treatment Outcome
(22)
Retrospective Studies
(20)
Adult
(19)
Cardiovascular System & Cardiology
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Growth signals, inflammation, and vascular perturbations: mechanistic links between obesity, metabolic syndrome, and cancer

Platelet Factor 4/Heparin Antibodies in Blood Bank Donors

Argatroban Therapy in Heparin-Induced Thrombocytopenia With Hepatic Dysfunction

Effects of Argatroban Therapy, Demographic Variables, and Platelet Count on Thrombotic Risks in Heparin-Induced Thrombocytopenia

When heparins promote thrombosis : Review of heparin-induced thrombocytopenia

How Frequently Is Venous Thromboembolism in Heparin-Treated Patients Associated With Heparin-Induced Thrombocytopenia?

Platelet factor 4/heparin antibody (IgG/M/A) in healthy subjects: a literature analysis of commercial immunoassay results

Heparin-induced Thrombocytopenia, a Prothrombotic Disease

Argatroban Anticoagulation in Renal Dysfunction: A Literature Analysis

Calorie restriction and cancer prevention: a mechanistic perspective

The Pharmacokinetics and Pharmacodynamics of Argatroban: Effects of Age, Gender, and Hepatic or Renal Dysfunction

A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease

Argatroban for Suspected Heparin-Induced Thrombocytopenia: Contemporary Experience at a Large Teaching Hospital

Reducing thrombotic complications in the perioperative setting : An update on heparin-induced thrombocytopenia

Heparin-induced thrombocytopenia in the emergency department

Reducing Harm Associated with Anticoagulation: Practical Considerations of Argatroban Therapy in Heparin-Induced Thrombocytopenia

Compatibility of argatroban with abciximab, eptifibatide, or tirofiban during simulated Y-site administration

Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia

Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS-1): A randomized, placebo-controlled safety study

Risk Factors for Major Bleeding in Patients With Heparin-induced Thrombocytopenia Treated With Argatroban: A Retrospective Study

Etiology and Assessment of Hypercoagulability with Lessons from Heparin-Induced Thrombocytopenia

Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy

Reduced argatroban doses after coronary artery bypass graft surgery

Argatroban Anticoagulation in Obese Versus Nonobese Patients: Implications for Treating Heparin-induced Thrombocytopenia

Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy

Suchergebnisse filtern